S. Coskun Et Al. , "BRAF mutation, TERT promoter mutation, and HER2 amplification in sporadic or neurofibromatosis-related neurofibromas and malignant peripheral nerve sheath tumors: do these molecules have a signature in malignant transformation?," APMIS , vol.128, no.9, pp.515-522, 2020
Coskun, S. Et Al. 2020. BRAF mutation, TERT promoter mutation, and HER2 amplification in sporadic or neurofibromatosis-related neurofibromas and malignant peripheral nerve sheath tumors: do these molecules have a signature in malignant transformation?. APMIS , vol.128, no.9 , 515-522.
Coskun, S., GAMSIZKAN, M., Yilmaz, I., YALÇINKAYA, Ü., SUNGUR, M. A., Buyucek, S., ... Onal, B.(2020). BRAF mutation, TERT promoter mutation, and HER2 amplification in sporadic or neurofibromatosis-related neurofibromas and malignant peripheral nerve sheath tumors: do these molecules have a signature in malignant transformation?. APMIS , vol.128, no.9, 515-522.
Coskun, Sinem Et Al. "BRAF mutation, TERT promoter mutation, and HER2 amplification in sporadic or neurofibromatosis-related neurofibromas and malignant peripheral nerve sheath tumors: do these molecules have a signature in malignant transformation?," APMIS , vol.128, no.9, 515-522, 2020
Coskun, Sinem Et Al. "BRAF mutation, TERT promoter mutation, and HER2 amplification in sporadic or neurofibromatosis-related neurofibromas and malignant peripheral nerve sheath tumors: do these molecules have a signature in malignant transformation?." APMIS , vol.128, no.9, pp.515-522, 2020
Coskun, S. Et Al. (2020) . "BRAF mutation, TERT promoter mutation, and HER2 amplification in sporadic or neurofibromatosis-related neurofibromas and malignant peripheral nerve sheath tumors: do these molecules have a signature in malignant transformation?." APMIS , vol.128, no.9, pp.515-522.
@article{article, author={Sinem Coskun Et Al. }, title={BRAF mutation, TERT promoter mutation, and HER2 amplification in sporadic or neurofibromatosis-related neurofibromas and malignant peripheral nerve sheath tumors: do these molecules have a signature in malignant transformation?}, journal={APMIS}, year=2020, pages={515-522} }